Stay updated with breaking news from Biomedical Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Newcastle firm LightOx has received a grant of more than £1million to continue their revolutionary work to tackle oral cancer.
START-up firm AilseVax, which is developing the next generation of cancer vaccines, has become the 100th company to spin out of the laboratories at Belfast's Queen’s University.
Queen’s University Belfast has announced its 100th spin-out company - AilseVax - with seed funding of £1.5M from a group of investors.